Chronic lymphocytic leukaemia (CLL) cells, characterised by high CPT1 expression, exhibit an enhanced sensitivity to perhexiline compared to lymphocytes [97]. This evidence concerns the gene CPT1A and B-cell chronic lymphocytic leukemia.